How OFEV
Works

OFEV® (nintedanib) capsules is the only antifibrotic therapy FDA-approved in 3 indications:

  • to treat adults with a lung disease called idiopathic pulmonary fibrosis (IPF).
  • to treat adults with a long lasting (chronic) interstitial lung disease (ILD) in which lung fibrosis continues to worsen (progress).
  • to slow the rate of decline in lung function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD) (also known as scleroderma-associated ILD).

It is not known if OFEV is safe and effective in children.

What is an antifibrotic therapy?

An antifibrotic therapy is a drug that decreases the formation of scar tissue, also called fibrosis.

A CLOSER LOOK
AT OFEV

OFEV is designed to block some of the substances involved in the pathways that cause scarring of the lungs, also called pulmonary fibrosis.

HOW DOES OFEV HELP?

Targeting the pulmonary pathway

In this brief video, you'll learn how OFEV® (nintedanib) capsules are believed to work.

This video does not provide medical advice. Please consult with your healthcare provider if you have specific questions about your health.

OFEV is a prescription medication used to treat adults with a lung disease called idiopathic pulmonary fibrosis (IPF), to treat adults with a long lasting (chronic) interstitial lung disease in which lung fibrosis continues to worsen (progress), and to slow the rate of decline in lung function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD), also known as scleroderma-associated ILD).

It is not known if OFEV is safe and effective in children.

The formation of fibrosis involves many pathways. Blocking substances involved in these pathways may help slow down the formation of fibrosis.

OFEV was designed to block some of the substances that are involved in the fibrotic pathways (scarring of the lungs).

The way OFEV is believed to work was suggested in early laboratory experiments. The way that OFEV may work was not studied in humans.